- 9 health systems on pharmacy, AI and OR strategy: 5 resources for healthcare leaders this week
- CMS Proposes TAVR Medicare Coverage is Potential Boost for Edwards Lifesciences
- Indiana Takes On Powerful Hospitals by Capping Prices They Charge Employers
- Prosper AI lands $30M backed by Andreessen Horowitz to build AI workforce for healthcare operations
- Hospital margins lag as expense growth outpaces inflation: 5 notes
- Every safety event has a cultural backstory – The hidden cost of dominant leadership in healthcare
- Franciscan Alliance CEO to retire
- Fish Oil Supplements May Be A Bust For Alzheimer's Prevention
- Prehab Can Boost Seniors' Recuperation From Spinal Fusion Surgery, Trial Finds
- Dog Owners Feel Similar Grief Whether Pets Euthanized, Die Naturally
- Ozempic Might Cut Risk Of Broken Bones, Study Says
- Massage Guns Can Cause Eye Damage, Vision Loss, Case Report Warns
- Hiring, pay and restructuring: 4 HR leaders on difficult workforce decisions
- First free dental clinic opens in New Jersey
- The week in hospital M&A
- 5 dental insurance changes dentists need to know from the past 15 days
- A new medical school is opening nearby. What do health systems do first?
- ‘Snowbirds’ and ‘med-à-terres’: The market behaviors shaping systems’ growth decisions
- Indiana dental office manager sentenced to 36 months in prison for Medicaid fraud
- OpenAI says new ChatGPT model tops physician-written health answers
- CMS’ accreditation overhaul: What it means for hospitals
- 5 cardiology leaders building the ASC ownership model
- What it actually takes to launch cardiac ablations in an ASC
- 5 federal, state legislative updates affecting the dental workforce
- How many dentists the largest DSOs support
- 8 new behavioral health projects to know
- Anesthesia has a usage problem not a workforce shortage, leaders say
- Remain or Reimagine: Free Interactive Tool Shows Dentists the value of remaining independent vs partnering with Elevate
- Pennsylvania dental group settles patient coverage lawsuit for $1M
- Pennsylvania physicians push back on consolidation with first-ever independent practice summit
- The ASC procedure list is growing — here’s what’s still missing
- wRVU pay, hospital subsidies don’t constitute Stark law fraud, court rules
- Specialty dentists’ compensation has climbed 39% since 2019
- ASCs’ block time hoarding problem
- Oregon prosecutors urge state to fix mental health system
- Arkansas lab pays $30M to settle kickback allegations tied to gastroenterology practices
- The case for layering behavioral healthcare models
- Why dentistry needs a revamp
- Rural, independent Kansas hospitals launch clinically integrated network
- Nova Southeastern launches 1st anesthesiologist assistant program in Nevada
- 12 behavioral health services, facility closures | 2026
- Higher, short-acting opioid doses linked to 8% lower discharge risk: 4 notes
- Cardiologists push back on CMS’ proposed pay policy changes
- 14,700 bottles of antidepressant recalled over impurity concerns
- FTC orders Aurobindo to divest 4 drugs to complete $250M Lannett acquisition
- Congressional Budget Office calls for more research on No Surprises Act unintended impacts
- 7 DSOs making headlines
- HHS opens applications for $700M in mental health, addiction funding, with $96M for new STREETS program
- Ebola Infections Climb, Could Take Year To Contain, Health Officials Say
- How Northwell is using paramedics to close behavioral healthcare gaps
- Feeling Sleepy During the Day? It Could Be a Warning Sign for High Blood Pressure
- FTC, states sue transgender health association over 'misleading' gender care guidance
- Healthcare organizations still struggle to operationalize AI at scale: Arcadia survey
- Pfizer hunts for new CFO as Denton prepares to hang up gloves, wave goodbye to pharma
- Major League Pitchers Might Avoid Elbow Injuries By Altering Their Approach, Simulation Suggests
- Birth Control Pills Might Increase Binge Eating Risk, Study Finds
- Women Might Lower Their Heart Risk By Lifting Weights, Study Says
- Personalized Brain Implant Provides Step-By-Step Walking Boost For Parkinson's Patients
- Amid industry’s cell therapy automation push, Cellares and Ori dominate the field: report
- Most Americans Are Surviving Cancer. But The Mental Health Challenges Can Persist.
- Listen to the Latest ‘KFF Health News Minute’
- Arrests of Immigrant Parents Create Mental Health Crisis for Children
- Sandwiched Between Caring for Kids and Aging Parents? Reach Out for Resources
- Readers Curse Medical Debt and Defend Spelling Therapy
- Novo's success with oral Wegovy has been fueled by 'familiarity': Spherix
- Preparing for LEAD: Why post-acute visibility is the key to long-term value-based success
- 20 new behavioral health study findings to know
- 31 behavioral health executive moves to know
- Centerstone names COO
- One Medical Seniors reports data breach of third-party vendor impacting 'limited' number of patients
- A look at Epic's long-term play to build tech for operations, starting with scheduling
- U.K. Moves To Ban Social Media For Children
- Pregnant Woman Exposed to 45 Common Chemicals, Study Finds
- OhioHealth reaches settlement with DOJ, Ohio AG on antitrust lawsuit
- 4 years after snub, GSK partnership helps Spero get Utebzi across FDA finish line
- Despite 'decent' data, Verastem rethinks options for approved oncology combo in pancreatic cancer
- OIG report raises red flags about maternal health 'ghost networks' in Medicaid managed care
- Why It’s Time to Sunset AI Point Solutions and Consolidate Platforms
- Lantern, Marathon Health team up to launch integrated care management model
- The New Frontier of Care Management: Bridging the Empathy Gap with Intelligence
- Novo Nordisk opens Czech plant and unveils $29M upgrade to China facility
- Whoop, HealthEx partner to connect members’ medical records and biometric data
- GSK runs first DTC ad for would-be asthma blockbuster Exdensur
- Novo security breach claimed by hacking groups seeking multi-million-dollar ransoms: reports
- After FDA sign-off, Colorado's drug import plan faces tough road ahead
- Lower Risk Of Death, Clots Among Autoimmune Patients Taking GLP-1 Drugs
- Surgical Menopause Tied To Worse Sexual And Urinary Symptoms
- Post-Op Delirium Common In Seniors, But Not All Hospitals Screen For It
- Nortiva purrs into action with long-acting Lynx platform salvaged from Langer startup
- Why one life insurer is going big on health incentives
- Weekly Rundown: Lumeris adds symptom-checking tool to AI platform; DeepIntent rolls out agentic AI tool for healthcare marketers
- Before you build or buy care navigation AI, answer this
- Early-Onset Cancers Are On The Rise. Knowing Your Family History Is Crucial.
- Minimally Invasive Procedure Eases Arthritis Knee Pain, Study Finds
- More Americans Are Surviving Cancer. But the Mental Health Challenges Can Persist.
- Democrats Seek To Spotlight Rising Health Costs by Forcing Vote on Trump Regulation
- Tennessee Pharmacies Sell Potent Ivermectin, Led by Anti-Vaccine Doctor Who’s Taken ‘Bucketloads’
- Health services deal value holds steady in 2026 with higher bar for investment: PwC
- Big Pharma’s Big Brand: Inside Eli Lilly’s marketing culture
- CMS tightens oversight of accreditation organizations, limits fee-based consulting
- MedPAC offers a look at enrollment hiccups for Medicare beneficiaries
- CDC, FDA Tackle New World Screwworm, Including Drug Authorization
- 'Biopharma ecosystem is back to full health,' fueled by M&A: PwC
- Lifestyle Changes Can Reduce Your Risk For Multiple Chronic Diseases
- US telehealth utilization climbs 10.1% in Q1, led by mental health visits: Fair Health
- FDA, UK drug regulator deepen transatlantic ties with new liaison program
- People Walk, Exercise Less After Starting Ozempic, Zepbound
- Family Finances Shape Children’s Brain Development, Study Finds
- At-Home Blood Pressure Monitoring Reduces Risk of Heart Attack, Stroke
- Moderna hires Novartis vet to lead commercial, upsizes role for Hoge as potential launches loom
- Long-Awaited Rule Aims To Boost ACA Choices While Embracing Higher Deductibles
- Many Men Are Prescribed Testosterone Without Proper Testing
- Early-Onset Cancers Are on the Rise. Knowing Your Family History Is Crucial.
- Backed by Threat of Clawbacks, Feds Wield Tight Grip on $50B Rural Health Fund
- Stealth BioTherapeutics removes cloak to become Mighty
- Recipharm channels ‘multi-million-dollar' US manufacturing upgrade, targeting domestic biologics demand
- DeepIntent gives Helix an AI twist to help marketers query data
- PhRMA talks up the power of ‘Medicines First’ in new campaign
- Organic Baby Formula Recalled Following Botulism Cases
- Germany backs off plan to install variable discount pricing on drugs: report
- FDA Approves First Over-the-Counter Glucose Monitor for Children, The Stelo Glucose Biosensor System
- You've Won The Game
- IQVIA taps AI to put overlooked prescribers on marketers’ maps
- Many Patients Stop And Restart GLP-1 Meds, Study Finds
- Merck's Welireg-Keytruda pairing sticks the landing in adjuvant kidney cancer treatment with new FDA nod
- Half Of U.S. Parents Track Their Adult Children’s Location
- Taking GLP-1s While On BP Meds May Up Your Risk Of Dizzy Spells, Fainting
- Trust In CDC Plummets Under Trump Administration, New Poll Shows
- Fentanyl Users Take Daily Doses 60 Times The Lethal Level
- Final Rules For Medicaid Work Requirements Are Out. Here's What You Need To Know.
- Remarks to the US-CEE Connection: Transatlantic Challenges in Law, Business & Policy
- Influencers, Booze And Teens: What's Showing Up In Their Feeds?
- Health 'War Room,' Digital Tools Are Tracking Disease Risks During World Cup
- Food Labels and Restrictions Can Lower Childhood Obesity Rates, Study Finds
- Tourette Patients Face High Suicide Risk, Pain And Discrimination
- Have A Risk-Taking Teen? This Brain Chemical Might Be Responsible, Researchers Say
- Statement Regarding Minimum Pricing Increments and Access Fee Caps
- Statement at the SEC Open Meeting on the Trade-Through Rule and Locked and Crossed Markets Provisions of Regulation NMS
- Disorder Protection Rule: Statement on the Proposed Amendments to Rule 611 and Other Provisions of Regulation NMS
- Statement on the Proposed Amendments to Regulation NMS
- This Old House: Improving and Remodeling Our Registered Offering and Filer Status Regimes
- How lab data powers precision commercialization to drive therapy adoption
- Peirce Out: Remarks at the U.S. Chamber of Commerce Capital Markets Summit
- Medtronic Advances Hugo Robotic Surgery Platform with Key FDA Filings and Product Approvals
- Medtronic Posts Strongest Revenue Growth in a Decade, Driven by Cardiovascular and Surgical Businesses
- Boston Scientific Plans Indiana Distribution Center, 300 New Jobs
- “Harmonization: We’ll Have Lots to Talk About”
- Remarks at the Investor Advisory Committee Meeting
- A Quarter for Your Thoughts: Remarks at the Meeting of the SEC Investor Advisory Committee
- Remarks at the Investor Advisory Committee Meeting
Michigan healthcare freedom community forum
No one seems happy with President Trump’s actions to expand access to in vitro fertilization (IVF):
https://thehill.com/policy/healthcare/5561456-trump-ivf-action-mixed-reactions/
Trump’s IVF moves: ‘Huge leap’ or ‘broken promises’?
By Joseph Choi - October 18, 2025President Trump’s dual-pronged action on expanding access to in vitro fertilization (IVF) is garnering mixed reactions from lawmakers, advocates and medical groups, with some calling it a step in the right direction, if only to start the conversation.
Speaking from the Oval Office on Thursday, Trump announced new federal guidance on insurance coverage for IVF services, as well as his administration’s latest deal with a drug manufacturer under his “most favored nation” pricing policy.
The updated guidance from the Department of Labor, the Treasury Department and the Department of Health and Human Services (HHS) would make opting in to fertility benefits similar to opting in for dental or vision benefits as part of an employer’s insurance plan.
EMD Serono, the manufacturer of commonly used infertility treatments like Gonal-F, announced it would be offering its “leading IVF therapies” at steep discounts. The company said in a press release that the agreement came with an exemption from Section 232 tariffs that the White House had threatened against pharmaceutical companies.
On the campaign trail, Trump — who called himself the “father of IVF” on Thursday — had vowed to make IVF available to everyone, either by the government funding it or by requiring insurers to cover it. The initiatives announced Thursday resemble neither of these plans.
Still, the announcement was well-received by some groups championing fertility services.
Moshe Margaretten, founder and president of Americans for IVF, called it a “huge leap forward in the fight to make fertility care affordable and accessible.”
“But as meaningful as this step is, we know our work is not finished. Indeed, the president said today that this is just the beginning,” Margaretten said. “We will continue working with the White House and Congress, advocating for further reforms until every family struggling with infertility can find the support and opportunity they deserve.”
Alabama Sen. Katie Britt (R) called the announcement the “most pro-IVF thing that any president in the history of the United States of America has done.”
Sean Tipton, chief advocacy and policy officer of the American Society for Reproductive Medicine, agreed with Britt’s assessment.
“But I think that indicates what a tremendously low bar that is. Because these policy announcements are not going to accomplish what the president said he wanted to accomplish, that is to make IVF available to everybody,” Tipton said.
He agreed that finances are a significant barrier to accessing IVF services, particularly in the U.S., but he wasn’t entirely sold on the plan requesting that employers consider covering fertility services for their employees.
“There are no sticks here. It’s all moderate carrots,” he said.
While acknowledging that a presidential endorsement of IVF coverage could go a long way, Tipton said this policy was “not nearly as valuable as a law,” and it’s unclear how many companies would actually be willing to cover the very costly procedure, with an IVF cycle costing between $15,000 and $20,000.
A reduction in the cost of Gonal-F is still significant, however, as the drug component of a cycle can cost between $5,000 and $6,000.
Sen. Elizabeth Warren (D-Mass.) blasted the nature of the policy, given that Congress is locked in a fight over ensuring continued health care coverage.
“It’s clear that Donald Trump lied when he told the American people he’d make IVF available to every family for free,” Warren said immediately after the announcement.
“Instead, Trump’s new genius plan is to rip away Americans’ health insurance and gut the CDC’s IVF team, then politely ask companies to add IVF coverage out of the goodness of their own hearts — with zero federal investment and no requirement for them to follow through. It’s insulting, and yet another one of Trump’s broken promises to American families,” she added.
Pushback from anti-abortion voices was also anticipated, given that unused embryos are regularly discarded or donated in the IVF process. Trump was asked about this anticipated criticism, which he dismissed by saying, “You can’t get more pro-life than this.”
“Any policy in this space, from the White House or Congress, must treat the lives of the smallest children in the highest regard,” Marjorie Dannenfelser, president of the anti-abortion group Susan B. Anthony Pro-Life America, said in a statement, reiterating her organization’s stance that “human embryos should not be destroyed.”
“We support focusing on restorative fertility treatments to help couples struggling with infertility, and urge high ethical and medical standards for the IVF industry,” she added. “Too often, the IVF industry is given blanket immunity — despite growing numbers of horror stories like rogue practitioners switching embryos, ignoring basic safety standards, or negligently destroying embryos.”
Granting embryos personhood was at the core of the lawsuit that pushed IVF into the national conversation last year when the Supreme Court of Alabama ruled that frozen embryos could be considered the same as children. This temporarily put IVF services in the state on pause, with clinics apprehensive of risking legal action.
Republican lawmakers found themselves in a uniquely difficult position: They concurred with the court’s findings while also being reticent to support blocking IVF services. Democrats, in turn, cited the ruling as an escalation of the overturning of Roe v. Wade, placing blame on Trump for nominating Supreme Court justices who helped overturn the landmark ruling.
EMILY’s List, a major Democratic group that backs female Democratic candidates who support abortion access, called it “another sorry proposal” from Trump.
“While Republicans pretend to care about women, they’re actively working to strip millions of women of their health insurance and push essential health care out of reach,” EMILY’s List President Jessica Mackler said. “Making IVF more accessible and affordable is going to rely on securing Democratic power by taking back Congress and electing women leaders across states who will deliver real solutions for these families.”
Negative story on proposed IVF changes from States Newsroom:
Trump’s IVF announcement disappoints patients, raises concerns for doctor
By Kelcie Moseley-Morris - October 21, 2025Miraya Gran is the kind of person who Republican President Donald Trump and his administration say they are going to help with new policies on in vitro fertilization.
It took a second mortgage on her Minnesota house and a family fundraiser to afford the IVF treatment she needed to have her first child in 2021. Gran’s husband has male-factor infertility, and she has a genetic blood disorder, making it extremely difficult for them to conceive on their own. But unless the cost of IVF goes down a lot, Gran can’t afford to give her daughter a sibling.
“I’ve got two embryos waiting for me, and I’m not accessing them due to lack of insurance coverage,” she said.
But Gran doesn’t have much hope left that IVF costs will drop enough after Trump’s announcement at the White House on Thursday, Oct. 16. The president said his administration negotiated steep discounts on a key fertility drug, as well as a new regulation allowing employers to offer IVF coverage as a standalone policy like dental or vision. EMD Serono, a major pharmaceutical brand, will offer the medication at an 84% discount via direct sales on a government webpage called TrumpRX, according to a company representative who spoke at the White House event.
Gran said that isn’t good enough. The drug prices are only a portion of what makes treatment expensive. One IVF cycle ranges between $12,000 and $25,000 on average but can cost more depending on medical needs. Many people require more than one round of IVF to get pregnant.
Plus, the new policy only clears the way for employers to offer coverage options — it’s not required by the government.
“They have the ability to put the onus on insurance companies,” Gran said. “There really isn’t a solution for our community until we have insurance coverage.”
Trump campaigned on a promise to make IVF treatment free for all, either through federal funding or insurance, but has so far not fulfilled that promise.
Dr. Eve Feinberg is an OB-GYN professor at Northwestern University, and a reproductive endocrinologist and fertility specialist who treats IVF patients every day. She said lowering the cost of the drugs is a positive step, but that’s only about one-third of the cost of a typical IVF cycle — less in some cases.
“For some patients, the medications can go as high as half the cost,” Feinberg said. “If you have a good reserve of eggs, you require less medication. If you have a lower reserve, you’ll need more. So for some, it’s $3,000 … and for some, it’s $10,000.”
‘Restorative reproductive medicine’ not a replacement for IVF, doctor says
Trump’s promise to make IVF free is a difficult one to fulfill not only because of the overall cost but because of divisions among conservative groups about the ethics of the treatment. IVF requires the collection of as many eggs as possible that are then fertilized. Some are later destroyed because they would not make it after implantation in the uterus due to abnormalities or other medical factors.
The Alabama Supreme Court ruled in 2024 that embryos have the same legal rights as children, which threw the medical community into chaos and caused some Alabama IVF clinics to close. Later that year, the Southern Baptist Convention adopted an anti-IVF resolution stating the church’s opposition to the practice.
The ruling happened just as Latorya Beasley was waiting on a transfer date for the embryo she hoped would be her second child. Her clinic temporarily canceled appointments but eventually reopened, and she was able to have a second child. Beasley had IVF insurance through her employer, which only about 25% of companies with more than 200 employees offer nationwide, according to KFF. But there were still out-of-pocket costs.
“There was a point where we ran out of medicine for like one day, and we paid $1,000 out of pocket for that,” Beasley said. “And that was with insurance coverage.”
Feinberg said she was also worried about the aspects of the announcement that talked about “restorative reproductive medicine,” which is a newer field of medicine not recognized by the same medical boards guiding reproductive endocrinology. The practice has been promoted by the Heritage Foundation — a conservative advocacy organization that authored Project 2025 — as the “new frontier” of reproductive medicine.
“There were certain things said in the briefing that made me think the idea of fertility coverage, especially for companies whose beliefs and ideas are religiously focused and religiously based, that may mean offering restorative reproductive medicine and not offering IVF,” she said.
The restorative practice focuses on cycle tracking to conceive, as well as weight loss and nutrition. Feinberg said she had a patient who had been using those methods for four years with no success, and she was 43 by the time a reproductive specialist told her that her husband had such a low sperm count, there was no way they could conceive without medical intervention.
“He had a genetic mutation that the restorative reproductive medicine person was not trained to ever diagnose,” she said. “They could have and should have done IVF.”
Gran and Beasley said if the Trump administration put forward plans that made a real difference for families in need of IVF, they would be the first to celebrate it. But until then, the lack of action is frustrating.
“It just feels like I’m being sold a complete line from a traveling salesman, because until there’s actual substantiated change, I have no faith in what they say,” Gran said.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.






















